Efficacious recombinant influenza vaccines produced by high yield bacterial expression: A solution to global pandemic and seasonal needs

PLoS ONE

Volumn 3, Issue 5, 2008, Pages

  Song, Langzhou ^a   Nakaar, Valerian ^b   Kavita, Uma ^a   Price, Albert ^b   Huleatt, Jim ^b,c   Tang, Jie ^b   Jacobs, Andrea ^b   Liu, Ge ^a   Huang, Yan ^b   Desai, Priyanka ^b   Maksymiuk, Gail ^b   Takahashi, Virginia ^b   Umlauf, Scott ^a   Reiserova, Lucia ^a   Bell, Rodney ^a   Li, Hong ^a   Zhang, Yi ^a   McDonald, William F ^b   Powell, T J ^b   Tussey, Lynda ^a  

^a VaxInnate Corporation   (United States)

^b VaxInnate Corporation   (United States)

^c SANOFI PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; FLAGELLIN; HYBRID PROTEIN; INFLUENZA VACCINE; INFLUENZA VIRUS HEMAGGLUTININ; MONOCLONAL ANTIBODY; RECOMBINANT VACCINE; VIRUS ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; DRUG DESIGN; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG MANUFACTURE; DRUG POTENCY; DRUG PURIFICATION; DRUG RESPONSE; ESCHERICHIA COLI; FERMENTATION; IMMUNOGENICITY; IMMUNOREACTIVITY; INFLUENZA; MOUSE; NONHUMAN; PROTEIN CONFORMATION; PROTEIN EXPRESSION; PROTEIN FOLDING; SEASONAL VARIATION; VACCINATION; ANIMAL; CHEMISTRY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; IMMUNOLOGY; INFLUENZA VIRUS A; SEASON; SERODIAGNOSIS;

BACTERIA (MICROORGANISMS); MUS;

ANIMALS; ANTIBODIES, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; ESCHERICHIA COLI; INFLUENZA A VIRUS; INFLUENZA VACCINES; MICE; NEUTRALIZATION TESTS; PROTEIN CONFORMATION; SEASONS; VACCINES, SYNTHETIC;

EID: 48249121152     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0002257     Document Type: Article

References (18)

1. Smith DJ, Lapedes AS, de Jong JC, Bestebroer TM, Rimmelzwaan GF, et al. (2004) Mapping the antigenic and genetic evolution of influenza virus. Science 305: 371-376.
2. Hebert DN, Zhang JX, Chen W, Foellmer B, Helenius A (1997) The number and location of glycans on influenza hemagglutinin determine folding and association with calnexin and calreticulin. J Cell Biol 139: 613-623.
3. Bright RA, Ross TM, Subbarao K, Robinson HL, Katz JM (2003) Impact of glycosylation on the immunogenicity of a DNA-based influenza H5 HA vaccine. Virology 308: 270-278.
4. Blander JM, Medzhitov R (2004) Regulation of phagosome maturation by signals from toll-like receptors. Science 304: 1014-1018.
5. Blander JM, Medzhitov R (2006) Toll-dependent selection of microbial antigens for presentation by dendritic cells. Nature 440: 808-812.
6. Huleatt JW, Jacobs AR, Tang J, Desai P, Kopp EB, et al. (2007) Vaccination with recombinant fusion proteins incorporating Toll-like receptor ligands induces rapid cellular and humoral immunity. Vaccine 25: 763-775.
7. Huleatt JW, Nakaar V, Desai P, Huang Y, Hewitt D, et al. (2008) Potent immunogenicity and efficacy of a universal influenza vaccine candidate comprising a recombinant fusion protein linking influenza M2e to the TLR5 ligand flagellin. Vaccine 26: 201-214.
8. McDonald WF, Huleatt JW, Foellmer HG, Hewitt D, Tang J, et al. (2007) A West Nile virus recombinant protein vaccine that coactivates innate and adaptive immunity. J Infect Dis 195: 1607-1617.
9. Gamblin SJ, Haire LF, Russell RJ, Stevens DJ, Xiao B, et al. (2004) The structure and receptor binding properties of the 1918 influenza hemagglutinin. Science 303: 1838-1842.
10. Bizebard T, Gigant B, Rigolet P, Rasmussen B, Diat O, et al. (1995) Structure of influenza virus haemagglutinin complexed with a neutralizing antibody. Nature 376: 92-94.
11. Jeon SH, Arnon R (2002) Immunization with influenza virus hemagglutinin globular region containing the receptor-binding pocket. Viral Immunol 15: 165-176.
12. Caton AJ, Brownlee GG, Yewdell JW, Gerhard W (1982) The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype). Cell 31: 417-427.
13. Wiley DC, Wilson IA, Skehel JJ (1981) Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation. Nature 289: 373-378.
14. Wilson IA, Skehel JJ, Wiley DC (1981) Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution. Nature 289: 366-373.
15. Russell RJ, Gamblin SJ, Haire LF, Stevens DJ, Xiao B, et al. (2004) H1 and H7 influenza haemagglutinin structures extend a structural classification of haemagglutinin subtypes. Virology 325: 287-296.
16. Ha Y, Stevens DJ, Skehel JJ, Wiley DC (2002) H5 avian and H9 swine influenza virus haemagglutinin structures: possible origin of influenza subtypes. EMBO J 21: 865-875.
17. Rosenthal PB, Zhang X, Formanowski F, Fitz W, Wong CH, et al. (1998) Structure of the haemagglutinin-esterase-fusion glycoprotein of influenza C virus. Nature 396: 92-96.
18. Kilbourne ED, Easterday BC, McGregor S (1988) Evolution to predominance of swine influenza virus hemagglutinin mutants of predictable phenotype during single infections of the natural host. Proc Natl Acad Sci U S A 85: 8098-8101.